RECTAL VAGINAL DELIVERY SYSTEM(updated)
Page 1
Introduction
Pharmaceutical Technology II by Deniz UGUR PhD
Page 2
Overview of Rectal and Vaginal Drug Delivery
Uses: Localized treatment of rectal or vaginal conditions.
Commonality: Oral route is most often utilized for systemic drug delivery.
Emerging Alternatives: Parenteral, transdermal, and transmucosal routes (buccal, nasal, pulmonary, ocular, rectal, and vaginal) are becoming more favored for their advantages:
Bypass first-pass metabolism.
Avoid gastrointestinal side effects.
Improved patient compliance.
Page 3
Reasons for Choosing the Rectal Route for Systemic Drug Administration
Patient Conditions:
Inability to Swallow: Unconscious, anesthetized, perioperative patients.
Gastrointestinal Issues: Patients experiencing nausea or vomiting.
Age Factors: Very young or elderly patients.
CNS Disorders: Conditions such as epilepsy.
Drug Suitability: Drugs that cause gastrointestinal side effects, unpalatable drugs, or those extensively metabolized in the GI tract.
Page 4
Limitations and Challenges of Rectal and Vaginal Routes
Dosage Form Retention: Affected by peristalsis and vaginal fluid clearance. Mucoadhesive dosage forms can help.
Patient Compliance: Concerns due to anogenital associations, and sexual/defecation connections.
Mucosal Irritation: May deter patients from using these routes for chronic conditions.
Page 5
Market Insights
Market Size: Rectal and vaginal formulations account for less than 1% of the pharmaceutical market.
Page 6
Anatomy and Physiology of the Rectum
Structure: Flat wall surface, lacks villi, features three major folds (rectal valves).
Composition: One cell-layer thick epithelium with cylindrical and goblet cells producing mucus.
Temperature and Volume: Approx. 37 °C with about 3 mL rectal fluids (300 cm² surface area).
pH Level: Approximately 7.2–7.5, close to neutral.
Page 7
Rectal Absorption
Mechanism: Passive diffusion is the primary absorption method.
Bioavailability: Drug absorption varies significantly among individuals, typically lower than oral due to smaller surface area for absorption.
Page 8
Rectal Drug Absorption Process
Dosage Form Insertion: Triggers passive diffusion of dissolved drugs through rectal membrane.
Suspended Drugs: Must leave the vehicle to dissolve in rectal fluid before absorption can occur.
Page 9
Advantages of Rectal Drug Delivery
Safe Administration: Dosage can be easily removed if necessary.
Suitable for Fragile Drugs: Bypasses harsh gastrointestinal conditions.
Formulation Versatility: Both immediate and modified-release formats can be used.
Ideal for Special Populations: Elderly, terminally ill, paediatric, and unconscious patients.
Effective for Nauseous Patients: Useful preoperatively and postpartum.
Page 10
Limitations of Rectal Drug Delivery
Patient Acceptance: Generally poor, especially for long-term treatments.
Incorrect Positioning: Can lead to increased first-pass metabolism.
Retention Challenges: Dosage forms may not be retained effectively.
Expulsion Risk: Due to rectal wall motility.
Page 11
Drug Absorption Characteristics
Comparison with Oral Route: Absorption rate and extent lower due to smaller rectal surface area.
Blood Supply: Rich vascularization aids systemic circulation uptake.
Page 12
Positioning and Bioavailability of Dosage Forms
Influencing Factors: Proper dosage form positioning is crucial to avoid first-pass metabolism and enhance bioavailability.
Page 13
Physiological Factors Affecting Rectal Absorption
Surface Area Limitations: Small volume of rectal fluid (approx. 3 mL).
Fluid Composition and Characteristics: The effects of viscosity and rectal mucus thickness.
Rectal Contents: Any additional substances present affect absorption.
Motility: Changes in rectal wall movements impact drug retention.
Page 14
Delivery of Protein/Peptide-Based Drugs
Advantange: No esterase or peptidase activity in the rectum aids stability of peptide drugs.
Enhancers Inclusion: Use of absorption enhancers can improve administration outcomes but may irritate rectal mucosa over time.
Page 15
Local and Systemic Rectal Dosage Forms
Local Action: For conditions like hemorrhoids, anal fissures, colitis, and proctitis.
Systemic Action: Includes anti-asthmatic, anti-inflammatory, and analgesic medications.
Page 16
Categories of Rectal Preparations
Common Forms: Suppositories, tablets, solutions (including enemas), suspensions, and foams.
Page 17
Excipients in Rectal Dosage Forms
Common Additives: Viscosity enhancers, buffers, solubilizing agents, and preservatives.
Absorption Enhancers: Important for improving bioavailability, yet need safety assessments.
Local Irritation: Frequently reported with rectal formulations.
Page 18
Suppository Design
Definition: Single-dose preparations suitable for rectal use.
Composition: Active substances in fat or water-soluble bases, varying from 0.1% to 40% drug content.
Page 19
Suppository Types by Application Area
Rectal Suppositories: 2 g for adults, 1 g for children.
Vaginal Suppositories: Also called pessaries, usually drop or oval shaped (3-5 g).
Urethral Suppositories: Bougies, varying lengths and weight (e.g. 4 g for men, 2 g for women).
Page 20
Ideal Suppository Base Properties
Key Qualities:
Melts, dissolves, or disperses at body temperature.
Nonirritating and stable throughout storage.
Compatible with various drugs and allows optimal drug release.
Page 21
Types of Suppository Bases
Classes: Lipophilic (fatty) bases and water-soluble bases, chosen based on the hydrophilic nature of the drugs involved.
Page 22
Drug Release Mechanisms in Suppositories
Fatty Base Mechanism: Melting and spreading upon insertion.
Hydrophilic Base Mechanism: Dissolves in rectal fluids leading to drug absorption.
Page 23
Fatty Vehicles
Properties: Should melt at a temperature just below body temperature and have a narrow melting point range for optimal use.
Solidifying Process Importance: Slow cooling rate crucial for proper solidification to avoid quality defects.
Page 24
Viscosity of the Suppository Base
Importance in Manufacturing: Affects flow into moulds and sedimentation rate of suspended drug particles.
Impact on Drug Release: Viscosity influences spread and release rate of suspended drug particles.
Page 25
Water-Soluble Vehicles
Hydrophilic Bases: Glycerinated gelatin and polyethylene glycol (PEG) bases.
Challenges: Limited rectal fluid volume hampers complete dissolution of the base, leading to potential irritation.
Page 26
Categories of Suppositories: Indications and Adverse Effects
Local Anesthetics: Anal pain, local irritation.
Steroids: Hemorrhoids, systemic absorption concerns.
Astringents and Vasoconstrictors: Treatment and potential side effects.
Page 27
Drug Properties Influencing Absorption
Solubility in Rectal Fluid: Determines maximum concentration and absorption potential.
Need for Wetting Agents: To enhance lipophilic drug solubility.
Page 28
Drug Permeation into Rectal Membrane
Lipid Solubility Requirement: Essential for effective diffusion through the rectal membrane.
Influence of Drug Characteristics: Highly hydrophilic compounds may not diffuse effectively.
Page 29
Drug Solubility in Vehicle and Release Rate
Release Dynamics: Relationship between drug solubility in the vehicle and subsequent absorption rates.
Base Choice Rules: Hydrophilic compounds best matched with fatty bases and vice versa.
Page 30
Drug Solubility and Suppository Formulation Rules
Solubility | Choice of Base |
|---|---|
Low | Fatty base |
High | Aqueous base |
Low Fat/Low Water | Indeterminate |
Page 31
Drug Particle Size
Importance in Suspensions: Smaller particle size leads to higher dissolution rates; fine powders preferred to prevent sedimentation.
Page 32
Displacement Value in Formulation
Definition: Mass of drug displacing 1 g of suppository base.
Significance: Important for calculating required base amounts in formulations where the drug is suspended in molten base.
Page 33
Displacement Calculation Example
Reference Formula: Formula for displacement value calculations with specific variables defined.
Page 34
Displacement Calculation Example - Cocoa Butter Suppositories
Calculation Steps: Includes total weight of suppositories and drug content analysis for calculation.
Page 35
Worked Example - Displacement Value Calculation
Prescription Example: Detailed calculation steps for preparing morphine sulfate suppositories.
Page 36
Worked Example - Displacement Value for Morphine Suppositories
Steps: Calculate morphine and base requirements for a production order of suppositories.
Page 37
Summary of Displacement Calculations
Recap: Key steps in determining the required amount of base for medicated suppositories based on displacement.
Page 38
Common Additives in Suppository Forms
Types of Agents: Hardening agents, deagglomerators, solubility enhancers, and preservatives.
Page 39
Suppository Preparation Methods
Pour Moulding: Hot preparation involving melting and pouring into moulds.
Hand Moulding: Cold preparation method requiring cutting and rolling.
Page 40
Ideal Properties for Suppository Bases
Non-toxic and irritation-free.
Compatibility with active drugs.
Melt or dissolve in rectal fluid at body temperature.
Page 41
Alternative Rectal Preparations
Rectal Capsules: Similar to soft capsules filled with drug solutions.
Rectal Tablets: Less common due to slow disintegration.
Enemas: Liquid preparations facilitating direct drug delivery.
Page 42
Vaginal Drug Delivery Basics
Vagina Structure: Fibromuscular tube connecting the uterus to the external environment.
Mucosal Coating: Vaginal wall has protective and lubricating mucus.
Page 43
Vagina Anatomy and Functionality
Dimensions: Approx. 100 mm in length, positioned between the rectum and bladder.
Page 44
Vaginal Fluid Characteristics
Variability Factors: Changes based on age, menstrual cycle, and infections.
Page 45
Vaginal Fluid pH and Microflora
Health Protection: Slightly acidic pH <br> - Lactobacillus bacteria convert glycogen into lactic acid, crucial for maintaining healthy vaginal environment.
Page 46
Blood Supply to the Vagina
Circulatory Connections: Uterine and vaginal arteries with drainage via vaginal venous plexus.
Direct Transport Mechanism: Facilitates systemic delivery and can bypass first-pass metabolism.
Page 47
First Uterine Pass Effect
Mechanism Explained: Highlights how vaginal administration can lead to higher uterine concentrations of drugs.
Page 48
Drug Absorption from the Vagina
Absorption Mechanism: Primarily passive diffusion through a well-vascularized wall.
Page 49
Factors Influencing Vaginal Drug Absorption
Physiological Factors: Various properties affect absorption rates, including viscosity and pH.
Page 50
Vaginal Delivery Advantages
Dual local/systemic delivery avenues.
Avoids hepatic first-pass metabolism.
Preferential delivery to the uterus.
Page 51
Limitations of Vaginal Delivery
Dependency on gender.
Fluctuations due to hormonal levels.
Retention issues can also arise.
Page 52
Vaginal Dosage Forms: Local Effects
Infection Treatment: Bacterial and fungal infections, with localized hormone delivery and contraception.
Page 53
Vaginal Dosage Forms: Systemic Action
Utilization: Deployment of vaginal delivery for hormones and reproductive treatments with effective systemic absorption.
Page 54
Pessaries in Vaginal Administration
Formulation of Pessaries: Describe characteristics of vaginal suppositories similarly to rectal formulations.
Page 55
Considerations for Vaginal Suppository Formulations
Preformulation Consideration: Focus on drug solubility during formulation phase to avoid irritation.
Page 56
Vaginal Tablets
Characteristics: Solid preparations with similar formulation aspects to oral tablets, frequently encountered in tropical settings.
Page 57
Tablet Formulation Limitations and Solutions
Dissolution Challenges: Address dissolution in limited vaginal liquid volume, with proper placement recommended.
Page 58
Filler Selection in Tablet Manufacturing
Preferred Substrate: Lactose as a filler due to its compatibility with vaginal microflora.
Page 59
Additives in Vaginal Tablets
Inclusion Benefits: Emphasizes mucoadhesive polymers for stability and retention.
Page 60
Vaginal Capsules
Comparison to Rectal Capsules: Similar manufacturing principles, used for local delivery and formulated with soft capsule technology.
Page 61
Semisolid Vaginal Preparations
Types: Creams and gels for drug delivery, requiring quality control to prevent irritation.
Page 62
Mucoadhesive Technology in Vaginal Formulations
Modern Advances: Introduction of easily insertable gels and ideas for intravaginal vaccination.
Page 63
Vaginal Films
Overview: Easy-to-use polymeric films for drug delivery that enhance patient acceptance.
Page 64
Current Research Trends in Vaginal Films
Innovation Focus: Reformulation of existing drugs for better efficacy.
Page 65
Vaginal Contraceptive Film® (VCF®)
Active Ingredient: Nonoxynol 9 utilized for contraceptive effects, with ongoing research into new formulations.
Page 66
Vaginal Rings
Design and Administration: Rings capable of prolonged drug release, with historical contraceptive and hormone therapy uses.
Page 67
Future Trends in Vaginal Rings
Research Aims: Development of biodegradable options and their use in preventative healthcare (e.g., HIV prevention).
Page 68
Other Vaginal Liquid Preparations
Purpose: Used for cleansing and personal care, with requirements for stability and irritation prevention.
Page 69
Medicated Vaginal Tampons
Application: Used for brief drug delivery and matrix-based formulations made from polymers.
Page 70
Manufacturing of Rectal and Vaginal Dosage Forms
Moulding Processes: Key steps in lubricant application, base calibration, and homogenization of drug mixtures.
Page 71
Steps in Manufacturing Process
Cooling and Packaging: Ensuring accurate dosage and safety before distribution.
Page 72
Compression Methods in Manufacturing
Highlighting Appropriateness: Suitable for drugs sensitive to heat and needing careful handling.
Page 73
Solvent Casting Procedure for Films
Detailed Steps: Include casting, drying, trimming, and potential solvent residue checks.
Page 74
Hot-Melt Extrusion for Vaginal Rings
Detailed Production Steps: General breakdown of the component mixing and preparation process.
Page 75
Quality Control Tests for Dosage Forms
Pharmacopoeial Standards: Ensuring consistency in manufacturing through a range of tests.
Page 76
Drug Release Assessment Techniques
Specific Methodology: Paddle method and the considerations for testing at body temperature in vitro.
Page 77
Key Points Recap of Drug Delivery Routes
Systemic and Local Delivery: Emphasizing pros and cons of each route and their clinical relevance.
Page 78
Summary of Rectal and Vaginal Routes
Clinical Applications: Discuss suitable patient populations and acknowledgment of cultural aspects.